Incidence and outcome of post-transplant lymphoproliferative disorders in lung transplant patients: Analysis of ISHLT Registry
- 20 June 2020
- journal article
- research article
- Published by Elsevier in The Journal of Heart and Lung Transplantation
- Vol. 39 (10) , 1089-1099
Abstract
No abstract availableKeywords
All Related Versions
Funding Information
- International Society for Heart and Lung Transplants
This publication has 29 references indexed in Scilit:
- Post-Transplant Lymphoproliferative Disease (PTLD): Risk Factors, Diagnosis, and Current Treatment StrategiesCurrent Hematologic Malignancy Reports, 2013
- Associations Between EBV Serostatus and Organ Transplant Type in PTLD Risk: An Analysis of the SRTR National Registry Data in the United StatesAmerican Journal of Transplantation, 2012
- Epidemiology of Posttransplant Lymphoproliferative Disorders in Adult Kidney and Kidney Pancreas Recipients: Report of the French Registry and Analysis of Subgroups of LymphomasAmerican Journal of Transplantation, 2012
- Risk factors for post‐transplant lymphoproliferative disease in patients with cystic fibrosisClinical Transplantation, 2011
- Association of HLA Polymorphisms with Post-transplant Lymphoproliferative Disorder in Solid-Organ Transplant RecipientsAmerican Journal of Transplantation, 2011
- Risk factors for early‐onset and late‐onset post‐transplant lymphoproliferative disorder in kidney recipients in the United StatesAmerican Journal of Hematology, 2010
- Epstein-Barr Virus and Posttransplant Lymphoproliferative Disorder in Solid Organ Transplant RecipientsAmerican Journal of Transplantation, 2009
- Association of Human Leukocyte Antigen Haplotypes with Posttransplant Lymphoproliferative Disease After Solid Organ TransplantationTransplantation, 2006
- Pretransplantation Assessment of the Risk of Lymphoproliferative DisorderClinical Infectious Diseases, 1995
- Incidence of non-hodgkin lymphoma in kidney and heart transplant recipientsThe Lancet, 1993